Biosecurity Modernization and Innovation Act of 2026

This bill requires companies that synthesize DNA or RNA (like those selling synthetic nucleic acids) to screen customer orders for dangerous sequences and verify customer identities. It mandates a federal system to maintain a list of "sequences of concern" (DNA patterns that could create harmful pathogens), with regular updates based on public input and rapid additions for emerging threats. The bill also creates a "biotechnology governance sandbox" for testing new security tools and streamlines federal oversight by having agencies coordinate under one plan to reduce duplication. These rules apply directly to biotech manufacturers and distributors of gene synthesis equipment, aiming to prevent misuse while supporting innovation.